Diphenhydramine HCL Oral Suspension (Anhydrous)

How to Give Anhydrous Oral Suspension

Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:

1. Shake well each time to mix the medication (5-10 seconds).
2. Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
3. Hold your pet steady: a towel or helper can assist with squirmy pets.
4. Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
5. Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
6. Praise your pet and offer a treat or water (unless advised against feeding right after).
7. Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
8. Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.

The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.

Veterinarians most commonly consider diphenhydramine for patients presented with acute allergic reactions, such as those following insect stings, vaccinations or environmental allergen exposure. It is frequently discussed in the context of allergic dermatitis, where managing localized itching and swelling is a clinical objective. Additionally, because of its influence on the central nervous system, some veterinarians may discuss diphenhydramine for the management of motion sickness during travel or as a mild sedative for situational stress, though newer pharmacological options are often evaluated for these specific needs.

At a pharmacological level, diphenhydramine acts as a competitive antagonist at H1 receptor sites. It does not block the release of histamine from mast cells, but rather addresses the physiological response by blocking histamine from binding to its receptors on effector cells. This mechanism manages the vasodilation, increased capillary permeability and sensory nerve stimulation that characterize the inflammatory cascade. Furthermore, diphenhydramine possesses significant anticholinergic activity and crosses the blood-brain barrier, which shapes its broader physiological profile, including its influence on the vestibular system and its sedative properties. Your veterinarian will determine the clinical appropriateness of diphenhydramine based on your pet's species, weight, health status and the nature of the inflammatory or behavioral trigger.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.

Commonly observed effects following the administration of diphenhydramine include sedation, lethargy and localized digestive changes such as xerostomia (dry mouth), vomiting or diarrhea. Some animals, particularly feline patients, may exhibit a paradoxical excitement or increased activity level rather than the anticipated calming effect. Because of its anticholinergic properties, your veterinarian will monitor for observational signs such as decreased tear production, urinary retention or an increased heart rate. Owners should monitor their pet for any significant behavioral shifts or persistent changes in appetite and contact their veterinarian promptly with any concerns.

This medication is typically used with extra caution or avoided in patients with known glaucoma, cardiovascular disease, prostatic hypertrophy, obstructive gastrointestinal disease or severe hypertension. It is also carefully evaluated in pregnant or nursing animals. Significant interactions can occur if diphenhydramine is administered concurrently with other central nervous system depressants, specific anticholinergic medications or monoamine oxidase inhibitors (MAOIs). Owners should be particularly careful when selecting over-the-counter formulations to ensure they do not contain additional active ingredients, such as acetaminophen or decongestants, which are toxic to pets. Your veterinarian is the right person to provide guidance on the necessary duration of use and the proper administration schedule to ensure the management approach remains suitable for your pet's health.